back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-09-09 Tx date 2018-07-26 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Harvey, Matthew
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-09-09 Tx date 2018-09-05 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Harvey, Matthew
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$4,500,000
+9,000,000 vol $0.50 each |
9,000,000 | |
| Filed 2018-08-09 Tx date 2018-08-07 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Davis, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-09 Tx date 2018-08-07 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Davis, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-09 Tx date 2018-08-07 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Davis, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-05-22 Tx date 2018-05-15 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
$20,000
+200,000 vol $0.10 each |
200,000 | |
| Filed 2018-05-22 Tx date 2018-05-15 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
mcdermid, scott
4 - Director of Issuer
Direct Ownership
|
Warrants
36 - Conversion or exchange
|
$-20,000
-200,000 vol $0.10 each |
0 | |
| Filed 2018-02-20 Tx date 2018-02-05 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Sider, Derek
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-02-20 Tx date 2018-02-05 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Sider, Derek
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$212,800
+380,000 vol $0.56 each |
380,000 | |
| Filed 2018-02-06 Tx date 2017-09-18 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+100,000 vol $0.25 each |
100,000 | |
| Filed 2018-02-06 Tx date 2017-09-18 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Dancosse, Guy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-15 Tx date 2018-01-10 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-62,500
-250,000 vol $0.25 each |
4,884,000 | |
| Filed 2018-01-08 Tx date 2017-11-30 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-75,000
-300,000 vol $0.25 each |
6,095,000 | |
| Filed 2018-01-08 Tx date 2017-12-09 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-250,000
-1,000,000 vol $0.25 each |
5,095,000 | |
| Filed 2018-01-08 Tx date 2017-11-28 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$16,000
+40,000 vol $0.40 each |
40,000 | |
| Filed 2018-01-08 Tx date 2017-11-28 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+80,000 vol $0.25 each |
80,000 | |
| Filed 2018-01-08 Tx date 2017-12-22 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chiron Capital Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,500
+39,000 vol $0.50 each |
5,134,000 | |
| Filed 2018-01-08 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-08 Tx date 2016-11-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Withrow, MIke Withrow
4 - Director of Issuer
Holder: Chateau Jing Capital Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-14 Tx date 2017-12-11 |
$ARV
AREV Nutrition Sciences Inc. (formerly Immunall Science Inc.) |
Rehmann, Nils
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,800
-10,000 vol $0.58 each |
190,000 |